155 related articles for article (PubMed ID: 27694707)
1. Molecular image-directed biopsies: improving clinical biopsy selection in patients with multiple tumors.
Harmon SA; Tuite MJ; Jeraj R
Phys Med Biol; 2016 Oct; 61(20):7282-7299. PubMed ID: 27694707
[TBL] [Abstract][Full Text] [Related]
2. Automated classification of benign and malignant lesions in
Perk T; Bradshaw T; Chen S; Im HJ; Cho S; Perlman S; Liu G; Jeraj R
Phys Med Biol; 2018 Nov; 63(22):225019. PubMed ID: 30457118
[TBL] [Abstract][Full Text] [Related]
3. A statistically optimized regional thresholding method (SORT) for bone lesion detection in
Perk T; Chen S; Harmon S; Lin C; Bradshaw T; Perlman S; Liu G; Jeraj R
Phys Med Biol; 2018 Nov; 63(22):225018. PubMed ID: 30457117
[TBL] [Abstract][Full Text] [Related]
4. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Assessment of Early [
Harmon SA; Perk T; Lin C; Eickhoff J; Choyke PL; Dahut WL; Apolo AB; Humm JL; Larson SM; Morris MJ; Liu G; Jeraj R
J Clin Oncol; 2017 Aug; 35(24):2829-2837. PubMed ID: 28654366
[TBL] [Abstract][Full Text] [Related]
6. Role of
Jiménez Londoño GA; García Vicente AM; Amo-Salas M; Fúnez Mayorga F; López Guerrero MA; Talavera Rubio MP; Gutierrez Martin P; González García B; de la Torre Pérez JA; Soriano Castrejón ÁM
Rev Esp Med Nucl Imagen Mol; 2017; 36(4):241-246. PubMed ID: 28330596
[TBL] [Abstract][Full Text] [Related]
7.
Langsteger W; Rezaee A; Pirich C; Beheshti M
Semin Nucl Med; 2016 Nov; 46(6):491-501. PubMed ID: 27825429
[No Abstract] [Full Text] [Related]
8. Prospective comparative study of
Fonager RF; Zacho HD; Langkilde NC; Fledelius J; Ejlersen JA; Hendel HW; Haarmark C; Moe M; Mortensen JC; Jochumsen MR; Petersen LJ
Acta Oncol; 2018 Aug; 57(8):1063-1069. PubMed ID: 29447047
[TBL] [Abstract][Full Text] [Related]
9. Optimising CT-guided biopsies of sclerotic bone lesions in cancer patients.
Donners R; Fotiadis N; Figueiredo I; Blackledge M; Westaby D; Guo C; Fenor de la Maza MLD; Koh DM; Tunariu N
Eur Radiol; 2022 Oct; 32(10):6820-6829. PubMed ID: 35881184
[TBL] [Abstract][Full Text] [Related]
10. PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique.
Guo W; Hao B; Chen HJ; Zhao L; Luo ZM; Wu H; Sun L
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):25-32. PubMed ID: 27444682
[TBL] [Abstract][Full Text] [Related]
11. Use of articulated registration for response assessment of individual metastatic bone lesions.
Yip S; Jeraj R
Phys Med Biol; 2014 Mar; 59(6):1501-14. PubMed ID: 24594875
[TBL] [Abstract][Full Text] [Related]
12. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
[TBL] [Abstract][Full Text] [Related]
13.
Wondergem M; van der Zant FM; Knol RJJ; Burgers AMG; Bos SD; de Jong IJ; Pruim J
World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431
[TBL] [Abstract][Full Text] [Related]
14. Needle track recurrence after transrectal prostate biopsy detected by ¹⁸F-Choline PET-CT.
Garcia-Bennett J; Henríquez I; Zugazaga Cortazar A; Fuertes J
Rev Esp Med Nucl Imagen Mol; 2015; 34(2):128-9. PubMed ID: 25037682
[No Abstract] [Full Text] [Related]
15.
Hazelton J; Kim S; Boerner JL; Podgorski I; Perk T; Cackowski F; Aoun HD; Heath EI
Prostate; 2023 Sep; 83(12):1193-1200. PubMed ID: 37211866
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of bone-seeking novel radiotracer
Passah A; Tripathi M; Ballal S; Yadav MP; Kumar R; Roesch F; Meckel M; Sarathi Chakraborty P; Bal C
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):41-49. PubMed ID: 27455986
[TBL] [Abstract][Full Text] [Related]
17. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.
Mosavi F; Johansson S; Sandberg DT; Turesson I; Sörensen J; Ahlström H
AJR Am J Roentgenol; 2012 Nov; 199(5):1114-20. PubMed ID: 23096187
[TBL] [Abstract][Full Text] [Related]
18. Initial experience with dual-energy computed tomography-guided bone biopsies of bone lesions that are occult on monoenergetic CT.
Burke MC; Garg A; Youngner JM; Deshmukh SD; Omar IM
Skeletal Radiol; 2019 Apr; 48(4):605-613. PubMed ID: 30343440
[TBL] [Abstract][Full Text] [Related]
19. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of extraskeletal computed tomography findings on 18F-NaF PET/CT performed for osseous metastatic disease evaluation.
Guo HH; Moradi F; Iagaru A
Nucl Med Commun; 2016 Sep; 37(9):975-82. PubMed ID: 27111100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]